# ğŸ§¬ CRMIT Exosome/EV Analysis Project

**Comprehensive Data Analysis Platform for Extracellular Vesicle Characterization**

[![Project Status](https://img.shields.io/badge/Status-Active-success)]()
[![Phase](https://img.shields.io/badge/Phase-1%3A%20Data%20Processing-blue)]()
[![Progress](https://img.shields.io/badge/Progress-8%25-yellow)]()
[![Deadline](https://img.shields.io/badge/Deadline-Mid%20January%202026-red)]()

---

## ğŸ“– Project Overview

This project develops an **end-to-end automated pipeline** for analyzing Extracellular Vesicles (EVs/Exosomes) using:
- **nanoFACS** (nano Flow Cytometry Analysis) - 70 FCS files
- **NTA** (Nanoparticle Tracking Analysis) - 86 text files
- **AWS S3** cloud storage for all data
- **Baseline + Iterations Workflow** - Compare test runs vs controls

**Client:** Bio Varam via CRMIT  
**Application:** iPSC-derived exosome characterization for therapeutic development  
**Timeline:** 12-14 weeks (Nov 13, 2025 - Early February 2026)

---

## ğŸ“ Repository Structure

```
â”œâ”€â”€ ï¿½ TASK_TRACKER.md              # Task tracking and progress monitoring (ACTIVE)
â”œâ”€â”€ ğŸ“„ EXECUTIVE_SUMMARY.md         # 2-page quick reference for meetings
â”œâ”€â”€ ğŸ—ï¸ UNIFIED_DATA_FORMAT_STRATEGY.md  # Data schema definitions with baseline workflow
â”œâ”€â”€ ï¿½ DATA_FORMATS_FOR_ML_GUIDE.md # Parquet vs JSON/CSV analysis
â”œâ”€â”€ ğŸ” CRMIT_ARCHITECTURE_ANALYSIS.md   # Architecture validation (80% alignment)
â”œâ”€â”€ ğŸ“ MEETING_PRESENTATION_MASTER_DOC.md  # 93-page presentation guide
â”œâ”€â”€ ğŸ†• MEETING_INSIGHTS_ANALYSIS_NOV13.md  # Latest meeting findings (Baseline workflow)
â”œâ”€â”€ ğŸ“‹ UPDATE_SUMMARY_NOV13.md      # Nov 13 changes log
â”œâ”€â”€ ğŸ“š Literature/                  # Scientific references and standards
â”‚   â”œâ”€â”€ FCMPASS_Software-Aids-EVs-Light-Scatter-Stand.pdf
â”‚   â”œâ”€â”€ Mie functions_scattering_Abs-V1.pdf
â”‚   â””â”€â”€ Mie functions_scattering_Abs-V2.pdf
â”œâ”€â”€ ğŸ”¬ nanoFACS/                    # Flow cytometry data (FCS files)
â”‚   â”œâ”€â”€ 10000 exo and cd81/         # CD81 antibody titration (21 files)
â”‚   â”œâ”€â”€ CD9 and exosome lots/       # CD9 testing + lot variability (24 files)
â”‚   â””â”€â”€ EXP 6-10-2025/              # Dilution series experiment (25 files)
â”œâ”€â”€ ğŸ“Š NTA/                         # Nanoparticle tracking data (TXT files)
â”‚   â”œâ”€â”€ EV_IPSC_P1_19_2_25_NTA/     # Passage 1 (27 files)
â”‚   â”œâ”€â”€ EV_IPSC_P2_27_2_25_NTA/     # Passage 2 (28 files)
â”‚   â”œâ”€â”€ EV_IPSC_P2.1_28_2_25_NTA/   # Passage 2.1 (31 files)
â”‚   â””â”€â”€ Dataset 1.xlsx              # Consolidated NTA results
â””â”€â”€ ğŸ’» Project IT data/              # Analysis scripts and processed data
    â”œâ”€â”€ Take path and meta convert to csv.py  # FCS parser (existing)
    â”œâ”€â”€ metatest.csv                # Sample metadata output
    â”œâ”€â”€ test.csv                    # Sample event data
    â””â”€â”€ Technical documentation/
```

---

## ğŸš€ Quick Start

### Prerequisites
```bash
Python 3.8+
Git
```

### Installation
```bash
# Clone the repository
git clone https://github.com/isumitmalhotra/CRMIT-Project-.git
cd CRMIT-Project-

# Create virtual environment
python -m venv venv
source venv/bin/activate  # On Windows: venv\Scripts\activate

# Install dependencies (coming soon)
pip install -r requirements.txt
```

---

## ğŸ“š Documentation

| Document | Description |
|----------|-------------|
| **[TASK_TRACKER.md](TASK_TRACKER.md)** | Real-time task status and progress tracking (PRIMARY) |
| **[EXECUTIVE_SUMMARY.md](EXECUTIVE_SUMMARY.md)** | 2-page quick reference for stakeholder meetings |
| **[UNIFIED_DATA_FORMAT_STRATEGY.md](UNIFIED_DATA_FORMAT_STRATEGY.md)** | Data schema definitions with baseline + iterations workflow |
| **[CRMIT_ARCHITECTURE_ANALYSIS.md](CRMIT_ARCHITECTURE_ANALYSIS.md)** | Architecture validation vs CRMIT design (80% alignment) |
| **[MEETING_INSIGHTS_ANALYSIS_NOV13.md](MEETING_INSIGHTS_ANALYSIS_NOV13.md)** | Nov 13 meeting findings (baseline workflow discovery) |
| **[DATA_FORMATS_FOR_ML_GUIDE.md](DATA_FORMATS_FOR_ML_GUIDE.md)** | Parquet format analysis (12-20x compression vs JSON) |
| `docs/` (Coming Soon) | Technical guides, API docs, user manuals |

---

## ğŸ¯ Project Phases

### âœ… Phase 0: Setup & Planning (COMPLETE)
- [x] Repository setup
- [x] Data organization
- [x] Comprehensive documentation

### ğŸŸ¡ Phase 1: Data Processing (IN PROGRESS - 8%)
- [ ] **Task 1.1:** Enhanced FCS Parser (Parquet + Baseline workflow + S3)
- [ ] **Task 1.2:** NTA Parser (ZetaView text files + S3)
- [ ] **Task 1.3:** Data Integration (Baseline comparison + ML-ready dataset)
- [ ] **Task 1.6:** AWS S3 Storage Integration â­ NEW (Client requirement)
- â¸ï¸ **Task 1.4/1.5:** TEM Module (DEFERRED - no sample data yet)

### â³ Phase 2: Analysis & Visualization (NOT STARTED)
- [ ] Exploratory data analysis
- [ ] Interactive dashboard
- [ ] Quality control module

### â³ Phase 3: Machine Learning (NOT STARTED)
- [ ] Predictive models
- [ ] Pattern recognition
- [ ] Anomaly detection

### â³ Phase 4: Deployment (PLANNING)
- [ ] Automated pipeline
- [ ] Web application & API
- [ ] Production deployment

---

## ğŸ“Š Current Data Assets

### Flow Cytometry Data (nanoFACS)
- **70 FCS files** across 3 experimental batches
- **26 parameters** per sample (FSC, SSC, 6 fluorescence channels)
- **~339K events per file** (23.7M total events)
- **Workflow:** 1 biological sample = 5-6 FCS files (baseline + iterations)
- **Experiments:** CD81/CD9 antibody optimization, SEC vs Centrifugation

### Nanoparticle Tracking (NTA)
- **86 TXT files** across 3 passages (P1, P2, P2.1)
- **Size distribution** (D10, D50, D90) and **concentration** measurements
- **11-position scanning** for spatial uniformity validation
- **Typical:** 1 NTA measurement per biological sample

### Storage
- **AWS S3** for all raw and processed data (client approved)
- **Parquet format** for processed data (78% compression vs CSV)

---

## ğŸ”¬ Key Scientific Questions

1. â“ What is the optimal antibody concentration for CD81 and CD9?
2. â“ Which preparation method is better (SEC vs Centrifugation)?
3. â“ How consistent are EVs across different cell passages and lots?
4. â“ What are the ideal dilution factors for each assay?
5. â“ **How much does marker expression increase vs baseline (isotype)?** â­ NEW
6. â“ Can we predict EV quality from early measurements?

**NEW Workflow Understanding (Nov 13, 2025):**
- Scientists run baseline (isotype control) FIRST
- Then run SAME biological sample 5-6 times with different antibodies
- System must compare each test to its baseline
- Calculate % increase, fold change, statistical significance

---

## ğŸ› ï¸ Technology Stack

**Languages:** Python 3.8+, SQL  
**Data Processing:** pandas, numpy, fcsparser, scipy, pyarrow, dask  
**Storage:** AWS S3 (boto3), Parquet format (Snappy compression)  
**Visualization:** matplotlib, seaborn, plotly  
**Dashboard:** Dash / Streamlit  
**ML/AI:** scikit-learn, XGBoost  
**Web:** FastAPI / Flask  
**Deployment:** Docker, AWS, Git

**Key Technologies:**
- **Apache Parquet:** 78% smaller than CSV, 10x faster loading
- **AWS S3:** Centralized cloud storage for all data
- **Dask:** Parallel processing for large datasets
- **Baseline Workflow:** Two-level ID system (biological_sample + measurement)

---

## ğŸ“ˆ Progress Tracking

**Overall Progress:** 8%  
**Deadline:** Mid-January 2026 (Phase 1: nanoFACS + NTA only)

| Phase | Progress | Status |
|-------|----------|--------|
| Phase 1: Data Processing | ğŸŸ¡ğŸŸ¡âšªâšªâšªâšªâšªâšªâšªâšª 15% | Planning complete, implementation starting |
| Phase 2: Analysis | âšªâšªâšªâšªâšªâšªâšªâšªâšªâšª 0% | Waiting on Phase 1 |
| Phase 3: ML & Analytics | âšªâšªâšªâšªâšªâšªâšªâšªâšªâšª 0% | Waiting on Phase 1 |
| Phase 4: Deployment | ğŸŸ¡ğŸŸ¡âšªâšªâšªâšªâšªâšªâšªâšª 10% | GitHub repo + documentation |

**Recent Updates (Nov 13, 2025):**
- âœ… Baseline + iterations workflow discovered and documented
- âœ… AWS S3 storage approved by client
- âœ… All schemas updated for baseline comparisons
- âœ… Task 1.6 added (S3 Integration)
- âœ… Timeline revised: 12-14 weeks

**Last Updated:** November 13, 2025

For detailed task status, see [TASK_TRACKER.md](TASK_TRACKER.md)

---

## ğŸ¤ Contributing

This is a client project for CRMIT/Bio Varam. For questions or collaboration:
- Review [PROJECT_ANALYSIS.md](PROJECT_ANALYSIS.md) for technical details
- Check [TASK_TRACKER.md](TASK_TRACKER.md) for current priorities
- Submit issues or pull requests

---

## ğŸ“ Changelog

### [0.4.0] - 2025-11-13
- ğŸ†• **Major Update:** Integrated Nov 13 meeting feedback
- Added baseline + iterations workflow support
- Added AWS S3 storage integration
- Created MEETING_INSIGHTS_ANALYSIS_NOV13.md (25 pages)
- Updated all schemas for biological_sample_id + measurement_id
- Added new Task 1.6 (S3 Integration)
- Timeline revised to 12-14 weeks
- Cleaned up 7 redundant documentation files

### [0.3.0] - 2025-11-13
- Added EXECUTIVE_SUMMARY.md (2-page quick reference)
- Added 12-week detailed sprint timeline
- Added CRMIT_ARCHITECTURE_ANALYSIS.md (118 pages)
- Added MEETING_PRESENTATION_MASTER_DOC.md (93 pages)
- Confirmed Phase 1 scope: nanoFACS + NTA only

### [0.2.0] - 2025-11-12
- Added UNIFIED_DATA_FORMAT_STRATEGY.md
- Added DATA_FORMATS_FOR_ML_GUIDE.md
- Added TASK_TRACKER.md for progress monitoring
- Added README.md

### [0.1.0] - 2025-11-12
- Initial repository setup
- Committed all project data (206 files)
- Organized folder structure

---

## ğŸ“ Contact

**Project Repository:** https://github.com/isumitmalhotra/CRMIT-Project-  
**Client:** Bio Varam via CRMIT  
**Data Scientist:** AI Solution Architect

---

## âš ï¸ Important Notes

- **Large Files:** Some data files exceed 50MB. Consider Git LFS for future additions.
- **Data Privacy:** Ensure compliance with data handling protocols.
- **Active Development:** This project is under active development.

---

## ğŸ“„ License

Proprietary - CRMIT/Bio Varam Client Project

---

**ğŸ”— Quick Links:**
- [ï¿½ Task Tracker](TASK_TRACKER.md) - **PRIMARY REFERENCE**
- [ğŸ“„ Executive Summary](EXECUTIVE_SUMMARY.md) - Quick 2-page overview
- [ğŸ—ï¸ Data Schema](UNIFIED_DATA_FORMAT_STRATEGY.md) - Technical specifications
- [ğŸ” Architecture Analysis](CRMIT_ARCHITECTURE_ANALYSIS.md) - Client alignment
- [ğŸ†• Latest Updates](MEETING_INSIGHTS_ANALYSIS_NOV13.md) - Nov 13 meeting findings
- [ğŸ”¬ Literature](Literature/) - Scientific references
- [ğŸ“Š nanoFACS Data](nanoFACS/) - 70 FCS files
- [ğŸ“ˆ NTA Data](NTA/) - 86 text files

---

*For the most up-to-date information, always refer to TASK_TRACKER.md and MEETING_INSIGHTS_ANALYSIS_NOV13.md*
